These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 6087460)

  • 1. Hepatic tumors induced by sex steroids.
    Mays ET; Christopherson W
    Semin Liver Dis; 1984 May; 4(2):147-57. PubMed ID: 6087460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic adenoma and focal nodular hyperplasia.
    Shortell CK; Schwartz SI
    Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
    Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH
    Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid related neoplasia in human liver.
    Barrows GH; Mays ET; Christopherson WM
    Princess Takamatsu Symp; 1987; 18():47-59. PubMed ID: 2852190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and benign tumors of the liver.
    Fitz JG
    West J Med; 1984 Feb; 140(2):260-7. PubMed ID: 6730471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and cancer of the liver: a review with two additional cases.
    Helling TS; Wood WG
    Am J Gastroenterol; 1982 Jul; 77(7):504-8. PubMed ID: 6283882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
    Ott R; Hohenberger W
    Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal nodular hyperplasia of the liver and hepatic cell adenoma in women on oral contraceptives.
    Bartók I; Decastello A; Csikós F; Nagy I
    Hepatogastroenterology; 1980 Dec; 27(6):435-40. PubMed ID: 6259038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oral contraceptive agents in the pathogenesis of liver tumors.
    Nissen ED; Kent DR; Nissen SE
    J Toxicol Environ Health; 1979; 5(2-3):231-54. PubMed ID: 224197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
    Herman P; Machado MA; Volpe P; Pugliese V; Vianna MR; Bacchella T; Machado MC; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):30-3. PubMed ID: 8029613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign hepatocellular tumors.
    Guzman IJ; Gold JH; Rosai J; Schneider PD; Varco RL; Buchwald H
    Surgery; 1977 Oct; 82(4):495-503. PubMed ID: 197654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex hormones and risk of liver tumor.
    Giannitrapani L; Soresi M; La Spada E; Cervello M; D'Alessandro N; Montalto G
    Ann N Y Acad Sci; 2006 Nov; 1089():228-36. PubMed ID: 17261770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic neoplasms associated with contraceptive and anabolic steroids.
    Ishak KG
    Recent Results Cancer Res; 1979; 66():73-128. PubMed ID: 219453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical, epidemiological, morphological and etiopathogenetic aspects of benign tumors of hepatocytic derivation, with description of a case of focal nodular hyperplasia].
    Bontempini L; Wittels M; Franceschini F
    Arch De Vecchi Anat Patol; 1981 Dec; 64(3):547-68. PubMed ID: 6284066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of liver cell adenoma and focal nodular hyperplasia].
    Akovbiantz A; Ackermann D; Bühler H; Schmid M
    Helv Chir Acta; 1980 Dec; 47(5):607-9. PubMed ID: 6259090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic and biliary repercussions of estrogens: dose or duration of treatment effect].
    Hecht Y
    Contracept Fertil Sex (Paris); 1991 May; 19(5):403-8. PubMed ID: 12316961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with the use of sex hormones.
    Taylor W
    Anticancer Res; 1987; 7(5B):943-8. PubMed ID: 2829703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features.
    Kerlin P; Davis GL; McGill DB; Weiland LH; Adson MA; Sheedy PF
    Gastroenterology; 1983 May; 84(5 Pt 1):994-1002. PubMed ID: 6299876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.